- Home
- ERAS vs SVM Comparison
ERAS vs SVM Comparison
Compare ERAS & SVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- SVM
- Stock Information
- Founded
- ERAS 2018
- SVM N/A
- Country
- ERAS United States
- SVM Canada
- Employees
- ERAS N/A
- SVM N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- SVM Precious Metals
- Sector
- ERAS Health Care
- SVM Basic Materials
- Exchange
- ERAS Nasdaq
- SVM Nasdaq
- Market Cap
- ERAS 723.8M
- SVM 663.6M
- IPO Year
- ERAS 2021
- SVM N/A
- Fundamental
- Price
- ERAS $1.90
- SVM $3.16
- Analyst Decision
- ERAS Strong Buy
- SVM Strong Buy
- Analyst Count
- ERAS 5
- SVM 1
- Target Price
- ERAS $5.70
- SVM $5.10
- AVG Volume (30 Days)
- ERAS 1.5M
- SVM 3.4M
- Earning Date
- ERAS 11-12-2024
- SVM 02-11-2025
- Dividend Yield
- ERAS N/A
- SVM 0.41%
- EPS Growth
- ERAS N/A
- SVM 63.39
- EPS
- ERAS N/A
- SVM 0.29
- Revenue
- ERAS N/A
- SVM $241,357,000.00
- Revenue This Year
- ERAS N/A
- SVM $31.86
- Revenue Next Year
- ERAS N/A
- SVM $10.34
- P/E Ratio
- ERAS N/A
- SVM $10.73
- Revenue Growth
- ERAS N/A
- SVM 16.71
- 52 Week Low
- ERAS $1.64
- SVM $2.22
- 52 Week High
- ERAS $3.45
- SVM $5.32
- Technical
- Relative Strength Index (RSI)
- ERAS 29.70
- SVM 50.46
- Support Level
- ERAS $1.77
- SVM $2.98
- Resistance Level
- ERAS $2.84
- SVM $3.27
- Average True Range (ATR)
- ERAS 0.18
- SVM 0.14
- MACD
- ERAS -0.07
- SVM 0.04
- Stochastic Oscillator
- ERAS 12.15
- SVM 71.79
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About SVM Silvercorp Metals Inc.
Silvercorp Metals Inc is a mineral mining company. It acquires, explores, develops, and mines precious and base metal mineral properties at its producing mines and exploration and development projects in China. The group produces silver, gold, lead, and zinc. The company creates shareholder's value by focusing on generating free cash flow from long-life mines; organic growth through extensive drilling for discovery; equity investments in potential world-class opportunities; ongoing merger and acquisition efforts to unlock value; and long-term commitment to responsible mining and ESG. The Company's producing mines are located in China, and current exploration and development projects are located in China and Mexico.